BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Biocontrol Medicals CardioFit System Receives CE Mark


1/7/2009 6:57:42 AM

YEHUD, Israel--(BUSINESS WIRE)--BioControl Medical announced today that its CardioFit system has received a CE Mark certification from KEMA, a Dutch notified body, in accordance with the European Active Implantable Medical Device Directive.

CardioFit is intended as a treatment for NYHA class II-III heart failure patients who have failed to achieve symptomatic improvement through standard evidence based management. The system works by applying electrical impulses to the vagus nerve. A sensing electrode in the right ventricle detects the patient’s heart rate and is used to control nerve stimulation. The system was approved for marketing in Europe based on the results of a recently completed pilot study.

“This is very exciting news for BioControl Medical as it provides an important seal of quality for CardioFit and opens important markets. We are grateful to the physicians who worked with us in the clinical study and provided us with the opportunity to introduce this therapeutic technology to clinical practice,” said Dr. Ehud Cohen, CEO of BioControl Medical.

About BioControl Medical

BioControl develops and markets advanced implantable devices for the treatment of autonomic disorders, conditions whereby the autonomic nervous system ceases to function properly, resulting in a disruption to the control of involuntary body processes. The devices enable controlled electrical stimulation of various nerves to achieve therapeutic results. For more information please contact: info@biocontrol-medical.com. To schedule an interview with Dr. Ehud Cohen, please contact Marjie Hadad, media liaison, at +972-54-536-5220 or at marjie@biocontrol.co.il.

Contact:

BioControl Medical Marjie Hadad, +972-54-536-5220 (media liaison) marjie@biocontrol.co.il

Source: BioControl Medical

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES